Cargando…

Monobenzone, a Novel and Potent KDM1A Inhibitor, Suppresses Migration of Gastric Cancer Cells

Lysine-specific demethylase1 (KDM1A) is generally highly expressed in various cancer tissues, and promotes the initiation and development of cancers via diverse cellular signaling pathways. Therefore, KDM1A is a promising drug target in many cancers, and it is crucial to find effective KDM1A inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Peizhi, Jia, Gang, Song, Zhiyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084583/ https://www.ncbi.nlm.nih.gov/pubmed/33935733 http://dx.doi.org/10.3389/fphar.2021.640949

Ejemplares similares

Optimization of Monobenzone-Induced Vitiligo Mouse Model by the Addition of Chronic Stress
por: Dong, Jing, et al.
Publicado: (2023)

Identification of Monobenzone as a Novel Potential Anti-Acute Myeloid Leukaemia Agent That Inhibits RNR and Suppresses Tumour Growth in Mouse Xenograft Model
por: Dong, Jingwen, et al.
Publicado: (2022)

Effective Melanoma Immunotherapy in Mice by the Skin-Depigmenting Agent Monobenzone and the Adjuvants Imiquimod and CpG
por: van den Boorn, Jasper G., et al.
Publicado: (2010)

Synthesis, Characterization, and in vivo Evaluation of a Novel Potent Autotaxin-Inhibitor
por: Hunziker, Daniel, et al.
Publicado: (2022)

Preclinical characterization of tunlametinib, a novel, potent, and selective MEK inhibitor
por: Liu, Yahong, et al.
Publicado: (2023)

OPC-167832, a Novel Carbostyril Derivative with Potent Antituberculosis Activity as a DprE1 Inhibitor
por: Hariguchi, Norimitsu, et al.
Publicado: (2020)

Novel Pan-Pim Kinase Inhibitors With Imidazopyridazine and Thiazolidinedione Structure Exert Potent Antitumor Activities
por: Sawaguchi, Yuichi, et al.
Publicado: (2021)

ASK120067 potently suppresses B-cell or T-cell malignancies in vitro and in vivo by inhibiting BTK and ITK
por: Song, Peiran, et al.
Publicado: (2022)

MicroRNA-3666 suppresses the growth and migration of glioblastoma cells by targeting KDM2A
por: Shou, Taotao, et al.
Publicado: (2019)

QSAR and molecular docking studies on designing potent inhibitors of SARS-CoVs main protease
por: Song, Fucheng, et al.
Publicado: (2023)

Anti-Melanoma immunity and local regression of cutaneous metastases in melanoma patients treated with monobenzone and imiquimod; a phase 2 a trial
por: Teulings, Hansje-Eva, et al.
Publicado: (2018)

Synthetic approaches to potent heterocyclic inhibitors of tuberculosis: A decade review
por: Dasmahapatra, Upala, et al.
Publicado: (2022)

Discovery of a Novel Na(v)1.7 Inhibitor From Cyriopagopus albostriatus Venom With Potent Analgesic Efficacy
por: Zhang, Yunxiao, et al.
Publicado: (2018)

Discovery and Identification of Pyrazolopyramidine Analogs as Novel Potent Androgen Receptor Antagonists
por: Wang, Lingyan, et al.
Publicado: (2018)

Inhibitors of Human 5-Lipoxygenase Potently Interfere With Prostaglandin Transport
por: Kahnt, Astrid S., et al.
Publicado: (2022)

Design, synthesis, and biological characterization of a potent STAT3 degrader for the treatment of gastric cancer
por: Li, Haobin, et al.
Publicado: (2022)

Imidazopyridines as Potent KDM5 Demethylase Inhibitors Promoting Reprogramming Efficiency of Human iPSCs
por: Dabiri, Yasamin, et al.
Publicado: (2019)

Discovery and Characterization of the Biflavones From Ginkgo biloba as Highly Specific and Potent Inhibitors Against Human Carboxylesterase 2
por: Song, Yun-Qing, et al.
Publicado: (2021)

A Novel Catecholopyrimidine Based Small Molecule PDE4B Inhibitor Suppresses Inflammatory Cytokines in Atopic Mice
por: Purushothaman, Baskaran, et al.
Publicado: (2018)

Discovery of New Potent anti-MERS CoV Fusion Inhibitors
por: Kandeel, Mahmoud, et al.
Publicado: (2021)

Discovery of Potent EGFR Inhibitors With 6-Arylureido-4-anilinoquinazoline Derivatives
por: Li, Meng, et al.
Publicado: (2021)

Discovery of a potent olaparib–chlorambucil hybrid inhibitor of PARP1 for the treatment of cancer
por: Qin, Hongyu, et al.
Publicado: (2023)

Novel MDM2 Inhibitor XR-2 Exerts Potent Anti-Tumor Efficacy and Overcomes Enzalutamide Resistance in Prostate Cancer
por: Wu, Meng, et al.
Publicado: (2022)

Discovery of N-(2-Aminophenyl)-4-(bis(2-chloroethyl)amino)Benzamide as a Potent Histone Deacetylase Inhibitor
por: Zhang, Lihui, et al.
Publicado: (2019)

Natural Potent NAAA Inhibitor Atractylodin Counteracts LPS-Induced Microglial Activation
por: Yang, Longhe, et al.
Publicado: (2020)

Discovery of Quercetin and Its Analogs as Potent OXA-48 Beta-Lactamase Inhibitors
por: Zhang, Yuejuan, et al.
Publicado: (2022)

Optimisation of a triazolopyridine based histone demethylase inhibitor yields a potent and selective KDM2A (FBXL11) inhibitor
por: England, Katherine S., et al.
Publicado: (2014)

A mass balance study of [(14)C]SHR6390 (dalpiciclib), a selective and potent CDK4/6 inhibitor in humans
por: Zhang, Hua, et al.
Publicado: (2023)

Quercetin Suppresses Human Glioblastoma Migration and Invasion via GSK3β/β-catenin/ZEB1 Signaling Pathway
por: Chen, Bo, et al.
Publicado: (2022)

Identification of a New Potent Inhibitor Targeting KRAS in Non-small Cell Lung Cancer Cells
por: Xie, Chun, et al.
Publicado: (2017)

Dihydroartemisinin suppresses bladder cancer cell invasion and migration by regulating KDM3A and p21
por: Wang, Tao, et al.
Publicado: (2020)

Histone Deacetylation Regulated by KDM1A to Suppress DACT1 in Proliferation and Migration of Cervical Cancer
por: Zeng, Lingjuan, et al.
Publicado: (2021)

Structure-Activity Relationships of Pentacyclic Triterpenoids as Potent and Selective Inhibitors against Human Carboxylesterase 1
por: Zou, Li-Wei, et al.
Publicado: (2017)

(+)-9-Trifluoroethoxy-α-Dihydrotetrabenazine as a Highly Potent Vesicular Monoamine Transporter 2 Inhibitor for Tardive Dyskinesia
por: Wang, Wenyan, et al.
Publicado: (2021)

Identification of a potent dual-function inhibitor for hIMPDH isoforms by computer-aided drug discovery approaches
por: Yazdani, Meysam, et al.
Publicado: (2022)

HZ-A-018, a novel inhibitor of Bruton tyrosine kinase, exerts anti-cancer activity and sensitizes 5-FU in gastric cancer cells
por: Liu, Danjing, et al.
Publicado: (2023)

A Robust Nanoparticle Platform for RNA Interference in Macrophages to Suppress Tumor Cell Migration
por: Liang, Shi, et al.
Publicado: (2018)

In vitro and in vivo Metabolism of a Potent Inhibitor of Soluble Epoxide Hydrolase, 1-(1-Propionylpiperidin-4-yl)-3-(4-(trifluoromethoxy)phenyl)urea
por: Wan, Debin, et al.
Publicado: (2019)

Chebulagic acid suppresses gastric cancer by inhibiting the AURKA/β-catenin/Wnt pathway
por: Zhao, Jing, et al.
Publicado: (2023)

Resistance to immune checkpoint inhibitors in gastric cancer
por: Liu, Kai, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ne9vcb9pvpp7jv02prfd90l9nl